![]() |
|
![]() | ||
|
Subject:
How to evaluate the portfolio of drugs under development of a pharma company?
Category: Business and Money Asked by: tateti-ga List Price: $2.00 |
Posted:
12 Jan 2006 05:15 PST
Expires: 24 Jan 2006 03:32 PST Question ID: 432408 |
I mean, in general terms. I am just looking for a general and comprehensive way of organizing the assessment of the portfolio of drugs under development of a pharma company. For example: unmet medical needs, patents, etc. A link to a website where this subject is presented will do it. |
![]() | ||
|
There is no answer at this time. |
![]() | ||
|
Subject:
Re: How to evaluate the portfolio of drugs under development of a pharma company?
From: kalunto-ga on 23 Jan 2006 13:31 PST |
will these help? http://www.enzo.com/therapeutics/product_pipeline.asp#HIV http://www.sciclone.com/product/zadaxin.php If it does fit what you need, let me know. cause i may have more information. |
Subject:
Re: How to evaluate the portfolio of drugs under development of a pharma company?
From: tateti-ga on 24 Jan 2006 03:27 PST |
Hi kalunto-ga Thank you for your comment, but that was not what I was looking for. You provided me with examples of pipelines or drugs under development. What I was looking for is a general and comprehensive way of organizing the assessment of the portfolio of drugs under development of a pharma company. For example: unmet medical needs, patents, etc. I have decreased the money I am offering for the answer because I have already found some answers by myself, for instance, the real-time scenario generation model http://www.phacilitate.co.uk/pages/phaciliate/article_ahmed.html Thanks again, kalunto. Hope any of the Google researchers can provide some useful answer... tateti |
If you feel that you have found inappropriate content, please let us know by emailing us at answers-support@google.com with the question ID listed above. Thank you. |
Search Google Answers for |
Google Home - Answers FAQ - Terms of Service - Privacy Policy |